Cyfuse

Since its establishment in 2010, Cyfuse has been committed to contributing to society in the medical field, including regenerative medicine and drug discovery, by creating three-dimensional tissues and organs that consist solely of cells, thereby promoting its business growth.In addition, the company "Cyfuse" (with "Cyto" meaning "cell" in its name) creates tissues and organs through the fusion of cells and various forms in collaboration with relevant parties. Up to now, I have been establishing businesses with others.At Cyfuse, three-dimensional tissues and organs produced using "spheroids (cell aggregates)" obtained through cell aggregation phenomena and the cell version of the 3D printer "Bio 3D Printer" are being practically applied as cellular products and delivered to patients. Furthermore, we will expand this technology globally from Japan and strive to become a leading company in the field of regenerative medicine in the near future.